Neurocognitive and neurophysiological endophenotypes in schizophrenia: An overview
- PMID: 37293386
- PMCID: PMC10249673
- DOI: 10.1016/j.bionps.2020.100017
Neurocognitive and neurophysiological endophenotypes in schizophrenia: An overview
Abstract
Schizophrenia (SCZ) is a severe psychotic disorder that affects up to 1% of the US population and it is associated with progressive impairment in social functioning and cognition. Nonetheless, despite its high burden, the pathophysiology of SCZ, including the genetic and biological mechanisms underlying the development and manifestation of the disorder, remains largely elusive. Endophenotypes are subtypes of biological markers that are more closely related to the genetic vulnerability for a disorder (e.g., SCZ). Recently, research on endophenotypes has identified several parameters that may prove useful in shedding light over the underlying neurobiology of SCZ. In this article, we provide an overview of the most established SCZ endophenotypes in the domains of neurocognition (attention deficits, working and verbal declarative memory dysfunctions) and neurophysiology (pre-pulse inhibition, anti-saccade impairment, event-related potential deficits) along with some novel, sleep-based measures (reduced sleep spindles and sleep slow waves). We also discuss recent conceptual advances in the field that may lead to novel, personalized treatment interventions for patients affected by this devastating mental illness.
Keywords: Endophenotypes; Psychosis; Schizophrenia.
Conflict of interest statement
Declaration of Competing Interest The authors declare no conflict of interest.
Similar articles
-
Sleep endophenotypes of schizophrenia: slow waves and sleep spindles in unaffected first-degree relatives.NPJ Schizophr. 2018 Feb 9;4(1):2. doi: 10.1038/s41537-018-0045-9. NPJ Schizophr. 2018. PMID: 29426848 Free PMC article.
-
Neurocognitive Endophenotypes of Schizophrenia and Bipolar Disorder and Possible Associations with FKBP Variant rs3800373.Med Arch. 2018 Nov;72(5):352-356. doi: 10.5455/medarh.2018.72.352-356. Med Arch. 2018. PMID: 30524168 Free PMC article.
-
Cluster analysis differentiates high and low community functioning in schizophrenia: Subgroups differ on working memory but not other neurocognitive domains.Schizophr Res. 2015 Oct;168(1-2):273-8. doi: 10.1016/j.schres.2015.07.011. Epub 2015 Jul 26. Schizophr Res. 2015. PMID: 26215505
-
Deconstructing schizophrenia: an overview of the use of endophenotypes in order to understand a complex disorder.Schizophr Bull. 2007 Jan;33(1):21-32. doi: 10.1093/schbul/sbl049. Epub 2006 Nov 6. Schizophr Bull. 2007. PMID: 17088422 Free PMC article. Review.
-
Neurocognitive performance as an endophenotype for bipolar disorder.Front Biosci (Elite Ed). 2014 Jan 1;6(1):89-103. doi: 10.2741/e694. Front Biosci (Elite Ed). 2014. PMID: 24389145 Review.
Cited by
-
An analysis of the clinical application of paliperidone palmitate injection based on real-world.Front Pharmacol. 2025 Mar 26;16:1501701. doi: 10.3389/fphar.2025.1501701. eCollection 2025. Front Pharmacol. 2025. PMID: 40206056 Free PMC article.
-
Motion and Form Perception in Childhood-Onset Schizophrenia.Pediatr Rep. 2024 Jan 15;16(1):88-99. doi: 10.3390/pediatric16010009. Pediatr Rep. 2024. PMID: 38251318 Free PMC article.
-
Multimodal evidence of mediodorsal thalamus-prefrontal circuit dysfunctions in clinical high-risk for psychosis: findings from a combined 7T fMRI, MRSI and sleep Hd-EEG study.Mol Psychiatry. 2025 Aug;30(8):3384-3392. doi: 10.1038/s41380-025-02924-2. Epub 2025 Feb 15. Mol Psychiatry. 2025. PMID: 39955469
-
The positive dimension of schizotypy is associated with a reduced attenuation and precision of self-generated touch.Schizophrenia (Heidelb). 2022 Jun 29;8(1):57. doi: 10.1038/s41537-022-00264-6. Schizophrenia (Heidelb). 2022. PMID: 35854009 Free PMC article.
-
Whose Signals Are Being Amplified? Toward a More Equitable Clinical Psychophysiology.Clin Psychol Sci. 2024 Mar;12(2):237-252. doi: 10.1177/21677026221112117. Epub 2022 Dec 14. Clin Psychol Sci. 2024. PMID: 38645420 Free PMC article.
References
-
- GBD 2016 Disease and Injury Incidence and Prevalence Collaborators, T, Abajobir AA, Abate KH, Abbafati C, Abbas KM, Abd-Allah F, Abdulkader RS, Abdulle AM, Abebo TA, Abera SF, Aboyans V, Abu-Raddad LJ, Ackerman IN, Adamu AA, Adetokunboh O, Afarideh M, Afshin A, Agarwal SK, Aggarwal R, et al., Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016, Lancet (London, England) 390 (10100) (2017) 1211–1259, doi:10.1016/S0140-6736(17)32154-2. - DOI - PMC - PubMed
-
- Leucht S, Cipriani A, Spineli L, Mavridis D, Örey D, Richter F, Samara M, Barbui C, Engel RR, Geddes JR, Kissling W, Stapf MP, Lässig B, Salanti G, Davis JM, Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: A multiple-treatments meta-analysis, Lancet 382 (9896) (2013) 951–962, doi:10.1016/S0140-6736(13)60733-3. - DOI - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources